Fortive $2.8 billion acquisition of Johnson & Johnson's sterilization business

6/6/2018
Asset acquisition

$ 2.8 billion

Announced

6/6/2018


Overview:

  • Conglomerate Fortive has made a $2.8 billion binding offer for Johnson & Johnson's sterilization business
  • Johnson & Johnson has 120 days to accept the offer.
  • If the offer is accepted, the deal would be expected to close by early 2019. 
  • Goldman Sachs acted as financial adviser for Fortive. 

Kurt Stumpo - Journalist

Jurisdiction:

United States

Deal type:

Asset acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Johnson & Johnson (Seller)


Party: Fortive (Acquirer)


Party: Fortive (Acquirer)